日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study

2023/24年度流感疫苗接种对德国炎症性风湿病患者的影响:一项全国性纵向自我报告研究的启示

Gente, Karolina; Ditz, Benedikt; Bormann, Eike; Al-Azem, Nadine; Burmester, Gerd R; Charaf, Salma; Fräbel, Christian; Gilliam-Feld, Gabriele; Klüser, Natalie; Knothe, Anna; Müller-Ladner, Ulf; Roth, Johannes; Schulze-Koops, Hendrik; Specker, Christof; Steinmüller, Mirko; Triantafyllias, Konstantinos; Hasseli, Rebecca

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

更正:巴瑞替尼治疗类风湿性关节炎的比较疗效、停药时间和患者报告结局:来自欧洲患者的多国前瞻性观察性 RA-BE-REAL 研究的 2 年数据

Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Östör, Andrew; Ng, Khai Jing; Gerwien, Jens; Zaremba-Pechmann, Liliana; Brnabic, Alan J M; Fautrel, Bruno

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)

菲戈替尼治疗类风湿性关节炎的初始反应研究(FIRST-RA)的原理、设计和方法

Pongratz, Georg; Alten, Rieke; Witte, Torsten; Pausch, Christine; Reinhold, Robert; Pittrow, David; Burmester, Gerd R

Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease

在患有类风湿性关节炎且心血管疾病风险较高或较低的患者中,比较upadacitinib与adalimumab的获益风险分析

Burmester, Gerd R; Mysler, Eduardo; Taylor, Peter; Hall, Stephen; Wick-Urban, Bettina; Garrison, Andrew; Gao, Tianming; Fish, Irina; Strengholt, Sander; Fleischmann, Roy

To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI)

利用荧光光学成像(FOI)优化手部风湿性疾病的诊断过程

Stumper, Nele; Berger, Jörn; Klotsche, Jens; Gedat, Egbert; Hoff, Paula; Schmittat, Gabriela; Burmester, Gerd R; Krönke, Gerhard; Backhaus, Marina; Haugen, Ida K; Ohrndorf, Sarah

Rheumatoid factors revisited in the age of biologic therapy

生物疗法时代类风湿因子再探

Avci, Ali Berkant; Feist, Eugen; Burmester, Gerd R

Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease

乌帕替尼的安全性概况:对超过27,000患者年的数据进行描述性分析,涵盖类风湿性关节炎、银屑病关节炎、中轴型脊柱关节炎、特应性皮炎和炎症性肠病

Burmester, Gerd R; Deodhar, Atul; Irvine, Alan D; Panaccione, Remo; Winthrop, Kevin L; Vleugels, Ruth Ann; Levy, Gweneth; Suravaram, Smitha; Palac, Hannah; Wegrzyn, Lani; Ford, Sharanya; Meerwein, Sebastian; Guttman-Yassky, Emma

Proteomic Analysis of FFPE Tissue Samples Identifies Potential Molecular Mechanisms Mediating Resistance to Radiotherapy in Rectal Cancer

对FFPE组织样本的蛋白质组学分析揭示了直肠癌放射治疗耐药的潜在分子机制

Zott, Tobias; Wolf, Michael; Plessl-Walder, Günter; Regele, Heinz; Bergmann, Michael; Meier-Menches, Samuel M; Gerner, Christopher; Silberhumer, Gerd R; Bileck, Andrea

HTK Is a Viable UW Alternative for Hypothermic Oxygenated Machine Perfusion of Liver Grafts Supporting a Single-Solution Protocol

HTK 是一种可行的 UW 替代方案,可用于肝移植的低温氧合机械灌注,支持单一溶液方案。

Dingfelder, Jule; Pereyra, David; Riha, Moriz; Becker, Nikolaus; Rauter, Laurin; Hackl, Hubert; Müller, Julian Flavio; Hammer-Purgstall-Bernd, Felix; Aiad, Monika; Eichelter, Jakob; Starlinger, Patrick; Silberhumer, Gerd R; Salat, Andreas; Berlakovich, Gabriela A; Györi, Georg; Soliman, Thomas

Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years

对接受filgotinib治疗的中重度类风湿性关节炎患者进行长达8.3年的综合安全性分析

Burmester, Gerd R; Gottenberg, Jacques-Eric; Caporali, Roberto; Winthrop, Kevin L; Tanaka, Yoshiya; Ekoka Omoruyi, Edmund V; Rajendran, Vijay; Van Hoek, Paul; Van Beneden, Katrien; Takeuchi, Tsutomu; Westhovens, René; Aletaha, Daniel